SBIR Phase I: Cost-Effective Anastomotic System Featuring Compliant Anastomoses
This Small Business Innovation Research (SBIR) Phase I project aims to develop a mechanical system for facilitating vascular anastomoses (end-to-side, end-to-end) technology that allows for the rapid and reproducible production of a non-penetrating, compliant vascular reconstruction. This one-shot technology represents a technical advance over the serial clip applier because the entire anastomotic circumference is formed simultaneously, thus facilitating the vascular reconstruction. Currently, there are no one-shot anastomotic systems on the market, thus the proposed technology would fill that much needed demand. This Phase I effort also will develop the manufacturing methods needed to produce these low-cost anastomotic devices that feature compliant polyurethane clips. Bench testing of the anastomoses will be conducted using well-established in vitro procedures. The broader impact/commercial potential of this project will be to reduce the time required to perform vascular anastomoses as well as vascular reconstruction in beating heart surgery. The $400 million surgical staples market urgently needs a new technology, as there is a significant unmet need to develop a novel, sutureless anastomotic device that applies 10 or 12 circumferential clips simultaneously. This should lead to rapid commercialization, especially since this advanced system will reduce surgical operating time.
Small Business Information at Submission:
STERLING BIOMEDICAL, LLC
2 DURHAM DR Lynnfield, MA 01940-1238
Number of Employees: